Rep. Cummings finds drug shortage gray market prospering

Targeting gray-market middlemen, Rep. Elijah Cummings has contacted 5 privately held drug distributors seeking information on how they obtained meds in short supply, how much they paid for them, as well as their selling price to hospitals, according to The Wall Street Journal. His letters to the companies may have been provoked by the discovery of a 650% average markup on such drugs in an August survey by Premier Healthcare Alliance, a healthcare purchasing network.

Cummings, who sits on the House Oversight and Government Reform Committee, provided the Journal with some early responses: Miami-based Allied Medical Supply offered to sell leukemia drug cytarabine for $990 per vial (typical cost about $12, according to Cummings). Premium Health Services of Columbia, MD, hocked cancer drug leucovorin for $270 per vial (more than 50x the typical sale price) and PRN Pharmaceuticals of Rockville, MD, offered cancer drug fluorouracil for $350 per vial (typically $15).

According to the story, gray market distributors are not thought to be causing drug shortages, but rather making a bad situation worse--at great profit.

- here's the WSJ story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.